Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl

Compare
Equity
Direct
Sector - Healthcare

NAV: ₹ 18.2 as on 20-09-2023

Fund Performance
zero opening, trading, fund transfer fee
14 people have invested ₹ 17K in Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl in the last three months

About the Fund

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl is an equity fund. This fund was started on 11 July, 2019. The fund is managed by Dhaval Shah. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl has ₹521 Cr worth of assets under management (AUM) as on Aug 2023 and is less than category average.
  2. The fund has an expense ratio 1.1.

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl Overview

Expense ratio
Expense ratio
1.09%
Benchmark
Benchmark
S&P BSE Healthcare PR
AUM
AUM
₹521 Cr
Inception Date
Inception Date
11 July, 2019
Min Lumpsum/SIP
Min Lumpsum/SIP
₹1000/₹500
Exit Load
Exit Load
1%
Lock In
Lock In
No Lock-in
TurnOver
TurnOver
30.7%

Fund Distribution as on (31-Aug-23)

  • Equity 97.5%

  • Debt & Cash 2.5%

Size breakup

Large cap
41.4%
Mid cap
33.9%
Small cap
22.2%

Sector Allocation

Aug'23

Jul'23

Jun'23

Health

97.1%

Financial Services

1.5%

Basic Materials

1.4%

Top Holdings of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl as on (31-Aug-23)

  • Equity

Equity Holdings29

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl: Monthly Changes Updates

All changes are between Jun'23 and Aug'23

Fund Performance

Aug'23
Jul'23
Jun'23
Fund Returns
0.23%
8.35%
9.41%
Nifty 500
-0.74%
3.21%
4.25%
  • This fund’s returns stands at 0.23% whereas the fund’s underlying benchmark Nifty 500 returns stands at -0.74% as on Aug'23
  • This fund outperformed Nifty 500 by 0.97% in Aug'23

AUM Change

Parameters
Aug'23
Jul'23
Jun'23
AUM
₹ 520.7 Cr
₹ 523.5 Cr
₹ 488.7 Cr
  • AUM of the fund stands at 520.7 Cr as of Aug'23
  • AUM decreased by 2.7 Cr between Aug'23 and Jul'23

Fund Portfolio Changes

Gainers & Losers in Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl portfolio Returns for the month of Aug

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl Fund Manager

Dhaval Shah

Dhaval Shah

Fund Manager of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl, since 11 July 2019

Fund Highlights

Risk meter
pointer

Very High Risk

Investors understand that their principal will be at Very High Risk
About the fund

About the fund

This fund has delivered an average annual returns of 21.16% since inception which is more than its category average return of 17.3%
Fund Allocations

Fund Allocations

This fund has an allocation of 97.52% in Equity, 0% in Debt and 2.48% in Cash related instruments
AUM size ₹521 Cr

AUM size ₹521 Cr

This fund has AUM of ₹521 Cr which is less than its category average of ₹ 1366 Cr
Expense Ratio 1.09%

Expense Ratio 1.09%

This fund has an expense ratio of 1.09% which is less than its category average expense ratio of 1.5%

Frequently Asked Questions

The current NAV of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl is ₹18.15 as on 20-Sep-2023.
Existing (Absolute + CAGR) as on 20-Sep-2023.
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
Absolute Returns
CAGR Returns
1 Month Returns
2.2%
2.2%
6 Month Returns
32.87%
32.87%
1 Year Returns
23.99%
23.99%
3 Years Returns
39.78%
11.81%
5 Years Returns
0%
0%
With INDmoney, the process of investing is very simple and involves zero commission.
  • Click Buy on the fund name.
  • Input the amount you are looking to invest.
  • Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
  • Select your bank account and proceed with Payment.
1.09% as on August 2023
₹521 Cr as on August 2023
Sun Pharmaceuticals Industries Ltd(14.12%), Cipla Ltd Shs Dematerialised(7.69%), Apollo Hospitals Enterprise Ltd(6.84%), Aurobindo Pharma Ltd(6.7%), Torrent Pharmaceuticals Ltd(6.25%) as on August 2023
Health(94.73%), Financial Services(1.47%), Basic Materials(1.32%) as on August 2023
The alpha ratio for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Alpha 1 Year
Alpha 3 Years
Alpha 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
0.58
-0.44
-
As on August 2023
The alpha for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Beta 1 Year
Beta 3 Years
Beta 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
0.98
0.94
-
As on August 2023
The Beta for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Sharpe Ratio 1 Year
Sharpe Ratio 3 Years
Sharpe Ratio 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
1.05
0.67
-
As on August 2023
The sharpe ratio for Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name
Standard Deviation 1 Year
Standard Deviation 3 Years
Standard Deviation 5 Years
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
14.12
15.07
-
As on August 2023
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.13 as on August 2023. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Dhaval Shah is the fund manager of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl
The Exit load of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Payout Inc Dist cum Cap Wdrl is 1%